Core Insights - The American Academy of Sleep Medicine Foundation (AASM Foundation) and Avadel Pharmaceuticals have celebrated five years of collaboration aimed at supporting early-career sleep researchers and future sleep physicians [4][8] - Avadel has been instrumental in funding initiatives such as the Young Investigator Research Forum (YIRF) and the AASM Fellow Boot Camp, which provide mentorship and training for trainees in sleep medicine [5][6] - The partnership has also facilitated the awarding of five grants totaling $1.7 million for projects addressing central disorders of hypersomnolence, in collaboration with patient advocacy groups [7] Company Contributions - Avadel became the inaugural corporate sponsor of the YIRF in 2021, empowering numerous trainees and junior faculty in sleep and circadian science [5] - The company was the lead sponsor of the AASM Fellow Boot Camp, which is designed to equip residents and physicians with essential skills for their fellowship year [6] - Avadel's contributions have significantly enhanced the AASM Foundation's capacity to fund innovative research and partnerships [7] Future Outlook - The AASM Foundation expresses enthusiasm for continuing collaboration with Avadel and other organizations to promote research and discovery in sleep medicine [8] - Avadel emphasizes its commitment to addressing unmet medical needs in sleep disorders and investing in the next generation of sleep specialists [8] About the Organizations - The AASM Foundation is the philanthropic arm of the American Academy of Sleep Medicine, focused on improving sleep health through investment in people, research, and communities [9] - Avadel Pharmaceuticals is a biopharmaceutical company dedicated to transforming medicines and improving patient outcomes, with its product LUMRYZ being the first FDA-approved once-at-bedtime oxybate for narcolepsy treatment [10]